(0.19%) 5 141.25 points
(0.17%) 38 508 points
(0.27%) 17 895 points
(-1.03%) $82.99
(1.72%) $1.956
(-0.26%) $2 341.00
(0.80%) $27.47
(0.10%) $923.00
(-0.19%) $0.933
(-0.17%) $11.01
(-0.24%) $0.798
(1.14%) $92.92
Live Chart Being Loaded With Signals
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases...
Stats | |
---|---|
Dagens volum | 173 828 |
Gjennomsnittsvolum | 153 496 |
Markedsverdi | 213.57M |
EPS | $0 ( 2024-04-04 ) |
Neste inntjeningsdato | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.66 |
ATR14 | $0.0130 (0.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-24 | Lewis Joel | Buy | 1 000 | Common Stock |
2023-12-31 | Czirr James C | Buy | 0 | |
2024-04-22 | Czirr James C | Sell | 21 323 | Common Stock |
2024-04-23 | Czirr James C | Sell | 3 677 | Common Stock |
2024-04-22 | Freeman Kevin D | Buy | 2 500 | Common Stock |
INSIDER POWER |
---|
24.13 |
Last 97 transactions |
Buy: 4 256 891 | Sell: 2 389 317 |
Volum Korrelasjon
Galectin Therapeutics Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
BRACU | 0.946 |
KIN | 0.945 |
ALGM | 0.929 |
ACVA | 0.929 |
NCAC | 0.925 |
CLBT | 0.921 |
PEGA | 0.92 |
NSIT | 0.92 |
AMYT | 0.919 |
SRRA | 0.919 |
10 Mest negative korrelasjoner | |
---|---|
DCRC | -0.928 |
AHPI | -0.923 |
IMV | -0.922 |
NCBS | -0.921 |
TENX | -0.92 |
LAWS | -0.919 |
CFMS | -0.919 |
TSHA | -0.918 |
VWE | -0.917 |
SGLB | -0.914 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Galectin Therapeutics Inc Korrelasjon - Valuta/Råvare
Galectin Therapeutics Inc Økonomi
Annual | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $-33 000.00 (0.00 %) |
EPS: | $-0.680 |
FY | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $-33 000.00 (0.00 %) |
EPS: | $-0.680 |
FY | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $-32 000.00 (0.00 %) |
EPS: | $-0.660 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-0.520 |
Financial Reports:
No articles found.
Galectin Therapeutics Inc
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.